RE: Has beaten its May 2013 high18 Jan 2020 20:05
I think the analysts know better than you. It’s not going anywhere near 2200+, no mind 2000p.
We have things called economic situations in front of us, so it’s not going to as easy as that. 1999-2000 went throw a value spurt. This current bull run is all about growth. But maybe this year we may revert to value stocks. GSK has had a good run of playing catch up, and that’s all it has been.
They still don’t have any new blockbusters to shout about just yet.
So. When the DowJ has grown like it has and this is an election year, we could be in for another bull run. That would be something to tell our kids about.
My preference pharma stocks are Sanofi looks very well placed after there recent acquisition, so does Novartis and Johnson & Johnson.
Sanofi actually plays 10% discount to mark sector.
This year, I intend to play it on value, but for stocks that have a good cash balance and low debt ratio.